SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/BDDA9EE742DF62535BA84FA8055CD00786994D9F6B212C690D94F65BB795097A1EE9603899A545854D832870062391EF>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/BDDA9EE742DF62535BA84FA8055CD00786994D9F6B212C690D94F65BB795097A1EE9603899A545854D832870062391EF
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/BDDA9EE742DF62535BA84FA8055CD00786994D9F6B212C690D94F65BB795097A1EE9603899A545854D832870062391EF
http://www.w3.org/2000/01/rdf-schema#comment
"The results suggest that HepaCAM and its cytoplasmic domain suppress the nuclear translocation of AR via Ran in prostate cancer (PCa). The cytoplasmic domain of HepaCAM may serve as a novel target for therapy in PCa."
xsd:string
http://purl.uniprot.org/uniprot/#_096548AFA1DB84539C6B413998E409F6CFB5A79CA26DD3624D37D0921D21977458B734978ADB2386C51F2C083EF1F1E4
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/BDDA9EE742DF62535BA84FA8055CD00786994D9F6B212C690D94F65BB795097A1EE9603899A545854D832870062391EF
http://purl.uniprot.org/uniprot/Q14CZ8
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/BDDA9EE742DF62535BA84FA8055CD00786994D9F6B212C690D94F65BB795097A1EE9603899A545854D832870062391EF
http://purl.uniprot.org/uniprot/#_Q14CZ8-mappedCitation-30664187
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/BDDA9EE742DF62535BA84FA8055CD00786994D9F6B212C690D94F65BB795097A1EE9603899A545854D832870062391EF